Seasonal influenza vaccine, standard quadrivalent.

Seasonal influenza vaccine, cell-based Flucelvax brand manufactured free of egg product. Recommended for those with history of severe anaphylaxis to egg or egg-based products.

Seasonal influenza vaccine, boosted formulation recommended for patients aged 65 and older. Better immune response has been shown with boosted/high dose vaccine in older patients.

Two-dose series Shingrix vaccine, separated by 2 to 6 months, to prevent herpes zoster (shingles) infection in patients age 50+ or patients with weakened immune system.

20-valent conjugate pneumonia vaccine (Prevnar 20) or 23-valent polysaccharide pneumonia vaccine (Pneumovax 23) depending on age and vaccine history.

Boostrix vaccine recommended every 10 years, after skin puncture injury, or patients who are pregnant.

Arexvy RSV vaccination for patients aged 60 and older.

Engerix-B vaccination, typically three dose series. Repeat doses recommended 1 month after initial dose and 6 months after initial dose.